Text Size

Pain Quality Study

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Merck
Information provided by (Responsible Party):
Mark Jensen, University of Washington
ClinicalTrials.gov Identifier:
NCT01321190
First received: March 21, 2011
Last updated: January 14, 2013
Last verified: January 2013
History of Changes
  Purpose

One way to better understand how various treatments for pain differ is to determine the effects of these treatments on different pain qualities or characteristics. For example, pain can be described as "hot", "electrical", "cold", "achy", and "piercing." In order to determine which pain quality/qualities that a pain treatment affects, researchers must develop measures of these pain qualities or characteristics. The purpose of this study is to learn more about the different pain qualities individuals who have low back pain, headaches and fibromyalgia experience. Identifying the common qualities of pain experienced by these groups will help researchers evaluate and develop more comprehensive pain quality measures, which will ultimately help them to be able to test the effectiveness of treatments for these different pain qualities.


Condition
Low Back Pain
Headache
Fibromyalgia

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Pain Quality in Individuals With Low Back Pain, Headache, and Fibromyalgia

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Washington:

Enrollment: 307
Study Start Date: June 2011
Estimated Study Completion Date: March 2013
Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
Low Back Pain
Individuals who experience bothersome low back pain.
Headache
Individuals who experience bothersome headaches.
Fibromyalgia
Individuals who experience bothersome fibromyalgia-related pain.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Individuals who have a formal diagnosis of one of the three conditions studied and have received services at either or both the Harborview Medical Center and the University of Washington Medical Center.

Criteria

Inclusion Criteria:

  • Speaks and understands English;
  • At least 18 years of age;
  • Confirms a diagnosis from a physician or certified medical provider of one of the three medical conditions (low back pain, headache, fibromyalgia), and that pain related to this diagnosis is still bothersome.
  • Has experienced bothersome pain associated with their diagnosis in the past three months of a sufficient intensity;
  • English is their first and primary language.

Exclusion Criteria:

  • Individuals would be excluded if they have more than one of the three pain diagnoses to be studied.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01321190

Locations
United States, Washington
University of Washington
Seattle, Washington, United States, 98108
Sponsors and Collaborators
University of Washington
Merck
Investigators
Principal Investigator: Mark P Jensen, PhD University of Washington
  More Information

No publications provided

Responsible Party: Mark Jensen, Principal Investigator, University of Washington
ClinicalTrials.gov Identifier: NCT01321190     History of Changes
Other Study ID Numbers: 40324-EA
Study First Received: March 21, 2011
Last Updated: January 14, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Back Pain
Fibromyalgia
Myofascial Pain Syndromes
Headache
Low Back Pain
Pain
Neurologic Manifestations
 Nervous System Diseases
Signs and Symptoms
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases

ClinicalTrials.gov processed this record on May 19, 2013